146 related articles for article (PubMed ID: 1980731)
21. Influence of dopamine agonists and an opiate antagonist on agaricus-induced catalepsy, as tested by a new method.
Sukul NC; Klemm WR
Arch Int Pharmacodyn Ther; 1988; 295():40-51. PubMed ID: 2907723
[TBL] [Abstract][Full Text] [Related]
22. Injection of a GABA antagonist into the mesopontine reticular formation abolishes haloperidol-induced catalepsy in rats.
Miwa H; Fuwa T; Yokochi M; Nishi K; Mizuno Y
Neuroreport; 1996 Nov; 7(15-17):2475-8. PubMed ID: 8981406
[TBL] [Abstract][Full Text] [Related]
23. Conditioned tolerance to haloperidol- and droperidol-induced catalepsy.
Nowak K; Welsch-Kunze S; Kuschinsky K
Naunyn Schmiedebergs Arch Pharmacol; 1988 Apr; 337(4):385-91. PubMed ID: 3405313
[TBL] [Abstract][Full Text] [Related]
24. Lack of the effect of ketamine on some dopaminergic behaviors in rats.
Morato GS; Takahashi RN
Braz J Med Biol Res; 1986; 19(3):403-9. PubMed ID: 3594006
[TBL] [Abstract][Full Text] [Related]
25. Involvement of caudate nucleus, amygdala or reticular formation in neuroleptic and narcotic catalepsy.
Dunstan R; Broekkamp CL; Lloyd KG
Pharmacol Biochem Behav; 1981 Feb; 14(2):169-74. PubMed ID: 7193882
[TBL] [Abstract][Full Text] [Related]
26. Influence of (-)-sulpiride and YM-09151-2 on stereotyped behavior in chicks and catalepsy in rats.
Wambebe C
Jpn J Pharmacol; 1987 Feb; 43(2):121-8. PubMed ID: 2883335
[TBL] [Abstract][Full Text] [Related]
27. Movement induced in cataleptic rats: differential effects produced by electrical stimulation of the lateral hypothalamus, substantia nigra, and reticular formation.
Mickley GA; Teitelbaum H
Psychopharmacology (Berl); 1978 Apr; 57(2):145-9. PubMed ID: 418447
[TBL] [Abstract][Full Text] [Related]
28. Effects of a Palicourea marcgravii leaf extract on some dopamine-related behaviors of rats.
Górniak SL; Palermo-Neto J; de Souza-Spinosa H
J Ethnopharmacol; 1990 Mar; 28(3):329-35. PubMed ID: 2335961
[TBL] [Abstract][Full Text] [Related]
29. Noradrenergic involvement in dopamine-dependent stereotyped and cataleptic responses in the rat.
Pycock C
Naunyn Schmiedebergs Arch Pharmacol; 1977 May; 298(1):15-22. PubMed ID: 560634
[TBL] [Abstract][Full Text] [Related]
30. Influences of estrogen and/or progesterone on some dopamine related behavior in rats.
Palermo-Neto J; Dorce VA
Gen Pharmacol; 1990; 21(1):83-7. PubMed ID: 2298391
[TBL] [Abstract][Full Text] [Related]
31. Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol.
Asper H; Baggiolini M; Burki HR; Lauener H; Ruch W; Stille G
Eur J Pharmacol; 1973 Jun; 22(3):287-94. PubMed ID: 4738903
[No Abstract] [Full Text] [Related]
32. Effect of manipulation of the GABA system on dopamine-related behaviors.
Sandoval MR; Palermo-Neto J
Braz J Med Biol Res; 1995 Jan; 28(1):88-99. PubMed ID: 7581034
[TBL] [Abstract][Full Text] [Related]
33. The enhancement of the hypomotility induced by small doses of haloperidol in the phase of dopaminergic supersensitivity in mice.
Masuda Y; Murai S; Saito H; Abe E; Fujiwara H; Kohori I; Itoh T
Neuropharmacology; 1991 Jan; 30(1):35-40. PubMed ID: 2046878
[TBL] [Abstract][Full Text] [Related]
34. EGYT-2509 a novel neuroleptic agent without extrapyramidal and endocrine side effects.
Gacsályi I; Petöcz L; Fekete MI; Bükkfálvi B; Görgenyi F; Arató M
Pol J Pharmacol Pharm; 1988; 40(6):613-9. PubMed ID: 2908364
[TBL] [Abstract][Full Text] [Related]
35. Motoneuron properties during motor inhibition produced by microinjection of carbachol into the pontine reticular formation of the decerebrate cat.
Morales FR; Engelhardt JK; Soja PJ; Pereda AE; Chase MH
J Neurophysiol; 1987 Apr; 57(4):1118-29. PubMed ID: 3585456
[TBL] [Abstract][Full Text] [Related]
36. Kainic acid injections in the striatum alter the cataleptic and locomotor effects of drugs influencing dopaminergic and cholinergic systems.
Sanberg PR; Pisa M; Fibiger HC
Eur J Pharmacol; 1981 Sep; 74(4):347-57. PubMed ID: 7197631
[TBL] [Abstract][Full Text] [Related]
37. Role of mesencephalic reticular formation in cholinergic-induced catalepsy and anticholinergic reversal of neuroleptic-induced catalepsy.
Hartgraves SL; Kelly PH
Brain Res; 1984 Jul; 307(1-2):47-54. PubMed ID: 6540616
[TBL] [Abstract][Full Text] [Related]
38. Effects of mafoprazine, a phenylpiperazine derivative, on the central dopaminergic system.
Yamamura M; Nakagawa H; Maeda K; Kinoshita K; Ishida R
Jpn J Pharmacol; 1989 Jul; 50(3):295-305. PubMed ID: 2569544
[TBL] [Abstract][Full Text] [Related]
39. Comparison of antipsychotic activity and discriminative stimulus effects of the novel acylprolyltyrosine containing compound, GZR-123, and sulpiride.
Asmakova LS; Kalinina TS; Ostrovskaya RU; Gudasheva TA; Zaitseva NI; Bondarenko NA; Voronina TA; Seredenin SB
Pharmacol Biochem Behav; 1999 Oct; 64(2):359-62. PubMed ID: 10515313
[TBL] [Abstract][Full Text] [Related]
40. Effect of piracetam, a cyclic GABA analogue, on haloperidol-induced catalepsy in the rat.
Balsara JJ; Bapat TR; Chandorkar AG
Indian J Physiol Pharmacol; 1980; 24(3):227-32. PubMed ID: 7193183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
